about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
35,511
XNAS Volume
High vol.+gain this week
XNAS 03 Jun, 2025 12:23 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..